Ad
related to: 4 Antibody Test
Search results
Summary of LDT Rule: An In-depth Look at the Final Rule Regarding Laboratory-Developed Tests | JD...
JD Supra· 2 days agoThe U.S. Food and Drug Administration (FDA or the Agency) issued a Final Rule on May 6, 2024 (89 FR 37286), that will, over the next four years,...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoEngineering the Future: Gene Synthesis Market's Phenomenal Growth Forecast 15.8% CAGR PR Newswire BOSTON, May 23, 2024 Global Gene Synthesis Market to Reach $4.1 Billion by ...
4 ways vaccine skeptics mislead you on measles and more
The Lake County Record-Bee· 1 day agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 2 days agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells -...
Nature· 6 days agoThis study reports a unexpected role in endothelial cells (ECs) for PCK2 in proteostasis, independent of its gluconeogenic activity. Perturbation of this role likely contributed to the angiogenic defects observed in ECs with reduced PCK2 levels.
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
WFRV 5 Green Bay· 5 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest progress of the Phase I/II clinical study of 9MW2821, a novel Nectin-4-targeting ...
JD Supra: EPA Finalizes Groundbreaking Rule to Regulate Two PFAS under CERCLA
JD Supra· 7 days agoOn Friday, April 19, 2024, the U.S. Environmental Protection Agency (EPA) released a pre-publication version of its Final Rule (the Rule) designating two widely used per- and polyfluoroalkyl ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody< ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 6 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoGlobal Immunoassay Market to Witness Growth at a CAGR of ~8% by 2030 | DelveInsight PR Newswire LAS VEGAS, May 27, 2024 The surge in the immunoassay market is mainly from the rising occurrence ...